T Acute Lymphoblastic Leukemia — Trials

T Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

117 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 47
Recruiting: 28
Ph III recruiting: 2
Growth YoY: —
Industry share: 9%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 52.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04315324	Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)	active not recruiting	Phase 1 / Phase 2	67	SWOG Cancer Research NetworkNETWORK	1	Sep 1, 2026	clinicaltrials
NCT03504644	Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia	active not recruiting	Phase 1 / Phase 2	40	ECOG-ACRIN Cancer Research GroupNETWORK	2	Aug 7, 2026